Allarity Therapeutics, Inc. (ALLR)
NASDAQ·Healthcare·Biotechnology
$1.38
+0.36%
Mkt Cap $19.94M
No analyst coverage available
We don't have analyst ratings or price target data for Allarity Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.